On the other hand, overexpression of PTEN has been shown to have inhibitory effects on insulin signaling, including decreased AKT activity and GLUT4 (glucose transporter 4) translocation to the cell membrane, showing the contribution to insulin resistance and then NAFLD progression (Figure 3) [58–60]. This evidence concerns the gene PTEN and metabolic dysfunction-associated steatotic liver disease.